Effect of self-monitoring intervention for Palliative cancer patients : a randomized controlled trial
Not Applicable
- Conditions
- Malingant disease
- Registration Number
- JPRN-UMIN000025322
- Lead Sponsor
- Tokyo Medical & Dental University Liaison Psychiatry & Palliative Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Severe cognitive dysfunction Severe psychiatric disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method QOL (EORTC QLQ-C-Pal) baseline, 1 weeks, 2 weeks
- Secondary Outcome Measures
Name Time Method QOL (FACIT-Pal),Anxiety and Depression baseline, 1 weeks, 2 weeks